Research Article
Triple Negative Breast Carcinoma: A Comparative Study between Breast Lesion and Lymph Node Metastases: A Preliminary Study
Table 1
Clinicopathologic and immunohistochemical characteristics of paired primary and lymph node metastatic triple negative breast carcinoma.
| | Patient | Age | Tumor size | PT | pN | Followup | Vital status | ER | PR | HER2 | CK5/6 | p63 | CAM5.2 | EGFR | CK17 | | (Years) | (mm) | (months) | (P/L) | (P/L) | (P/L) | (P/L) | (P/L) | (P/L) | (P/L) | (P/L) |
| | 1 | 55 | 24 | 2 | 1 | 82 | Alive | −/− | −/− | −/− | +/− | +/− | +/+ | 2/2 | −/+ | | (1/21) | DF | | 2 | 42 | 26 | 2 | 3 | 37 | Alive | −/− | −/− | −/− | +/− | −/− | +/+ | 0/2 | +/+ | | (5/25) | DF | | 3 | 65 | 21 | 2 | 2 | 42 | Alive | −/− | −/− | −/− | +/+ | +/+ | +/+ | 1/0 | −/− | | (4/20) | DF | | 4 | 55 | 60 | 4 | 3 | 42 | Died | −/− | −/− | −/− | +/+ | +/− | +/+ | 1/2 | +/+ | | (18/19) | | 5 | 62 | 65 | 4 | 2 | 47 | Died | −/− | −/− | −/− | +/+ | +/+ | −/+ | 1/3 | +/+ | | (8/11) | | 6 | 72 | 70 | 3 | 3 | 77 | Alive | −/− | −/− | −/− | −/− | −/− | +/+ | 2/2 | −/− | | (20/22) | DF | | 7 | 63 | 18 | 1 | 1 | 117 | Alive | −/− | −/− | −/− | −/− | −/− | −/− | 0/0 | −/− | | (2/24) | DF | | 8 | 56 | 30 | 2 | 1 | 65 | Alive | −/− | −/− | −/− | +/+ | −/+ | +/+ | 2/3 | +/+ | | (1/18) | DF | | 9 | 69 | 60 | 3 | 2 | 39 | Died | −/− | −/− | −/− | +/+ | +/+ | +/+ | 3/3 | +/+ | | (2/11) | | 10 | 58 | 60 | 3 | 3 | 84 | Died | −/− | −/− | −/− | −/+ | −/+ | +/+ | 2/2 | −/+ | | (23/26) | | 11 | 73 | 20 | 2 | 2 | 58 | Died | −/− | −/− | −/− | −/− | −/− | +/+ | 2/0 | −/− | | (4/20) |
|
|
DF: disease-free; P: primary breast carcinoma; L: lymph node metastases.
|
